Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Brian Spada Joins UMF|PerfectCLEAN as Regional Sales Manager – Healthcare Markets

Infection prevention expert bolsters UMF|PerfectCLEAN’s growing healthcare team Northbrook, Ill. – March 29, 2023 – Marking the latest expansion of its growing healthcare business, UMF|PerfectCLEAN welcomes Brian Spada as Regional Sales Manager – Healthcare Markets. Brian is an accomplished sales professional who is skilled in client services and results-oriented client management. Most recently with EvaClean, he brings years…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Brian Spada Joins UMF|PerfectCLEAN as Regional Sales Manager – Healthcare Markets

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Infection prevention expert bolsters UMF|PerfectCLEAN’s growing healthcare team

Northbrook, Ill. – March 29, 2023 – Marking the latest expansion of its growing healthcare business, UMF|PerfectCLEAN welcomes Brian Spada as Regional Sales Manager – Healthcare Markets. Brian is an accomplished sales professional who is skilled in client services and results-oriented client management. Most recently with EvaClean, he brings years of healthcare infection prevention expertise.

“We are thrilled to add Brian to our rapidly expanding healthcare team,” said Mark Hodgson, Vice President Sales – Healthcare Markets, UMF|PerfectCLEAN. “His deep knowledge of research-based, science-driven infection prevention solutions comes from years of partnering with some of the country’s leading healthcare facilities. He has helped such organizations achieve industry-leading safety scores and infection rates. Brian’s breadth of experience extends to education, and collegiate and professional sports. We look forward to working with Brian as we enter an exciting new phase of growth.”

Brian has proven abilities in sales and revenue growth, client based expansion, retention, and implementation. While at EvaClean, he co-developed the PurExcellance program, encompassing chemistry adaptation and a specialized clinical training program focused on reducing preventable healthcare associated infections (pHAIs) at healthcare facilities. He trained thousands of hospital staff members during his time there, and regularly exceeded performance goals. Prior to EvaClean, Brian was Regional Sales Manager at Interactive Metronome, where he brought their biometric technology platform to neurologists at leading hospitals and private practices in the Northeast and Caribbean. Before that, he spent more than nine years in sales at Steris, a division of SC Johnson’s DebMed, where he served major hospitals in the Northeast.

“I am thrilled to join UMF|PerfectCLEAN, which is on the cutting edge of infection prevention solutions, development, and innovation,” said Spada. “Committed to sustainability across the board, UMF|PerfectCLEAN is dedicated to ensuring safe environments for patients and healthcare professionals, alike. I am especially enthusiastic to join a company where caregivers and the customers they serve are the top priority.”

“We are thrilled to welcome Brian to our team,” said UMF|PerfectCLEAN CEO George Clarke. “Brian is already contributing to our mission of providing safe environments across all the markets we serve supported by best-in-class products, training, and solutions.”

About UMF Corporation

UMF Corporation is the leader in the research and development of high-performance products, programs and training for the infection prevention and commercial cleaning markets. Through extensive testing, exhaustive analysis and the commitment of significant human and financial resources, new antimicrobial technologies have been merged with innovative product designs that are redefining the future of clean®. LinkedIn.

Media Contact

Michelle Meek

(p) 773-220-3120

michelle@redpillchicago.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Physician burnout stems not just from workload but from loss of meaningful voice in healthcare organizations. Dr. Krishna Vedala discusses how primary care is mismanaged as a procedural business, how AI should free physicians from administrative work rather than replace them, and why physicians may need collective representation to restore trust between clinicians and administrators.

  • 01Physicians increasingly lack meaningful participation in organizational decisions, despite being closest to patients and responsible for care delivery.
  • 02Primary care requires complex, nuanced decision-making but is often managed with productivity expectations designed for procedural specialties, pushing work home and some physicians toward breaking point.
  • 03AI's highest value is reducing administrative burden and documentation so physicians have more time with patients, not replacing clinical judgment or human relationships.

Sep 8, 2026

MRI segmentation models can now label 80 structures, but deployment is the hard part

MRI segmentation models can now label 80 structures. TotalSegmentator MRI is an nnU-Net model that provides rapid segmentation of all major organs across all MRI sequences, according to Radiology Business. For health systems, deployment is the hard part.

  • 01The spread between 0.97 Dice on lungs and 0.54 on portal and splenic veins in MRSegmentator is the real operational story: enterprises need confidence flags and escalation paths, not a single headline score.
  • 02Hospitals planning radiation oncology and neuro volumetry programs can treat segmentation speedups as capacity gains only if downstream steps, contour review, dose planning inputs, and reporting templates, are standardized.

Sep 8, 2026

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512